SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Piper Sandler Initiates Coverage On Harpoon Therapeutics with Overweight Rating, Announces Price Target of $35

Piper Sandler analyst Tyler Van Buren initiates coverage on Harpoon Therapeutics (NASDAQ:HARP) with a Overweight rating and announces Price Target of $35.

Benzinga · 05/22/2020 10:01

Piper Sandler analyst Tyler Van Buren initiates coverage on Harpoon Therapeutics (NASDAQ:HARP) with a Overweight rating and announces Price Target of $35.